Alterations in Serotonergic Functions in Cocaine Addicts - 1

This study has been completed.

First Received on September 20, 1999. Last Updated on June 23, 2005 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	Department of Veterans Affairs
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000312

Purpose

The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.

Condition	Intervention	Phase
Cocaine-Related Disorders	Drug: M-CPP	Phase I

Study Type:	Interventional
Study Design:	Primary Purpose: Treatment
Official Title:	Alterations in Serotonergic Functions in Cocaine Addicts

Resource links provided by NLM:

Drug Information available for: Cocaine hydrochloride

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Side effects
Neuroendocrine changes
Psychological changes
Craving

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	25 Years to 50 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000312

Locations

United States, New York
VA Medical Center
Brooklyn, New York, United States, 11209

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Department of Veterans Affairs

Investigators

Principal Investigator:

Laure Buydens-Branchey, M.D.

Department of Veterans Affairs

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00000312 History of Changes
Other Study ID Numbers:	NIDA-09468-1, R01-09468-1
Study First Received:	September 20, 1999
Last Updated:	June 23, 2005
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on February 12, 2012